Epidiolex is a standardized, plant-derived Cannabidiol (CBD) extract formulated by GW Pharmaceuticals, a company that originates in England and also has offices located in California. The US Food and Drug Administration will undertake a “priority review” of data specific to the safety and efficacy of this new drug which...
Studies on cannabinoid anticonvulsant activity began in 1975, when Cannabidiol (CBD), and four CBD derivatives, (CBD-aldehyde-diacetate, 6-oxo-CBD-diacetate, 6-hydroxy-CBD-tri-acetate and 9-hydroxy-CBD-triacetate) were shown to protect against maximal electroshock convulsions in mice. Now it is given to children who suffer from epilepsy and adults who suffer from Parkinson’s Disease. CBD...
The World Health Organization (WHO), which is an agency of the United Nations (UN), and looked to as the navigator for many health organizations worldwide, has endorsed a recommendation from the Expert Committee on Drug Dependence (ECDD) that cannabidiol (CBD) based on the current information does not justify scheduling and...
As reported first by The Standard,on November 15, 2017 preliminary survey results from registered card holders under Charlee’s Law (HB105) were presented to the Health and Human Services Interim Committee on Utah’s Capitol Hill. Charlee’s Law was passed in 2014 to allow patients with epilepsy to buy CBD oil with...